239 related articles for article (PubMed ID: 11464443)
1. The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering.
Kolovou G
Curr Med Res Opin; 2001; 17(1):34-7. PubMed ID: 11464443
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
Lefer AM; Scalia R; Lefer DJ
Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
[No Abstract] [Full Text] [Related]
3. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-dependent effects of statins.
Wolfrum S; Jensen KS; Liao JK
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
6. Statins and direct vascular actions.
Mueck AO; Seeger H
Panminerva Med; 2003 Mar; 45(1):1-6. PubMed ID: 12682615
[TBL] [Abstract][Full Text] [Related]
7. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
9. Direct vascular effects of HMG-CoA reductase inhibitors.
Laufs U; Liao JK
Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin: two decades in a circle.
Kolovou GD; Katerina A; Ioannis V; Cokkinos DV
Cardiovasc Ther; 2008; 26(2):166-78. PubMed ID: 18485137
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.
Ma S; Ma CC
Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660
[TBL] [Abstract][Full Text] [Related]
13. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
14. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
15. HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque.
Morishita R; Tomita N; Ogihara T
Curr Drug Targets; 2002 Oct; 3(5):379-85. PubMed ID: 12182229
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
17. New nonlipid effects of statins and their clinical relevance in cardiovascular disease.
Undas A; Celińska-Löwenhoff M; Kaczor M; Musial J
Thromb Haemost; 2004 Jun; 91(6):1065-77. PubMed ID: 15175791
[TBL] [Abstract][Full Text] [Related]
18. Statins and ischemic stroke.
Liao JK
Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
[TBL] [Abstract][Full Text] [Related]
19. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
20. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
Liao JK
Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
